itraconazole – comparison of pbpk models for evaluation of clinical pk exposure and ddis
Published 3 years ago • 1K plays • Length 55:55Download video MP4
Download video MP3
Similar videos
-
59:49
pbpk modeling approaches to assess risks associated with bioequivalence in drug development
-
1:01:26
iq wg evaluation of pbpk models for organ-impaired populations
-
18:32
itraconazole
-
1:02:16
leveraging dermal pbpk modeling and simulation approaches
-
1:06:27
the importance of pbpk model validation and reproducibility in obstetric pharmacology
-
16:24
pbpk modeling and simulation used in assessing be for generic ophthalmic products (19of39)
-
59:49
optimising the cyp3a4 ontogeny in paediatric pbpk models – are we there yet?
-
4:23
itraconazole (sporanox) - uses, dosing, side effects | pharmacist review
-
33:19
drug transporter webinar: evaluation of ketoconazole & alt. clinical cyp3a4-5 inhibitors
-
17:53
itraconazole - drug/drug interactions
-
1:30:54
biopharmaceutic ivive informed pbpk model of ritonavir norvir
-
5:07
#itraconazole | uses, dosage, side effects & mechanism | sporanox
-
55:43
pbpk modelling to predict drug-biologic interactions with cytokine modulators
-
12:33
itraconazole - mechanism, side effects, precautions & uses
-
0:49
what are the uses of itraconazole?
-
1:22
labpad evolution, the pocket laboratory
-
15:14
cyp3a genetics and itraconazole | december 16, 2022
-
47:22
therapeutic drug monitoring of antifungals (webinar q&a): voriconazole, itraconazole, flucytosine
-
0:37
fda approves sivextro to treat skin infections